F star Therapeutics Inc (FSTX)       6.26  -0.07 (-1.11%)

6.26  -0.07 (-1.11%)

US30315R1077 - Common Stock - After market: 6.29 +0.03 (+0.48%)

Buy % Consensus

Analysts have set a mean price target of 30.4. This target is 385.56% above the current price.
FSTX was analyzed by 13 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about FSTX.
In the previous month the buy percentage consensus was at a similar level.
FSTX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 6.2621.2132.6430.4036.75 - 238.82% 421.41% 385.56% 487.06%

Up and Down Grades

Date Firm Action Rating
2022-06-24 SVB Leerink Downgrade Outperform -> Market Perform
2022-05-11 SVB Leerink Maintains Outperform
2021-08-17 SVB Leerink Maintains Outperform
2021-07-08 SVB Leerink Initiate Outperform
2021-06-09 B. Riley Securities Initiate Buy
2021-05-18 HC Wainwright & Co. Initiate Buy
2021-04-16 Oppenheimer Initiate Outperform
2021-04-08 William Blair Initiate Outperform
2021-03-24 Laidlaw & Co. Initiate Buy
2021-03-01 HC Wainwright & Co. Initiate Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA